Literature DB >> 16467508

Rosiglitazone (Avandia) and macular edema.

Claire Kendall, Eric Wooltorton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467508      PMCID: PMC1389823          DOI: 10.1503/cmaj.060074

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

2.  Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus.

Authors:  Michael Colucciello
Journal:  Arch Ophthalmol       Date:  2005-09
  2 in total
  9 in total

1.  Rosiglitazone and macular edema.

Authors:  Gurusamy Sivagnanam
Journal:  CMAJ       Date:  2006-08-01       Impact factor: 8.262

Review 2.  Waking up from the DREAM of preventing diabetes with drugs.

Authors:  Victor M Montori; William L Isley; Gordon H Guyatt
Journal:  BMJ       Date:  2007-04-28

3.  Retrospective analysis of rosiglitazone and macular oedema in patients with type 2 diabetes mellitus.

Authors:  Patrizio Tatti; Franco Arrigoni; Adriano Longobardi; Flavia Costanza; Patrizia Di Blasi; Domenico Merante
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

4.  Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy.

Authors:  Walter T Ambrosius; Ronald P Danis; David C Goff; Craig M Greven; Hertzel C Gerstein; Robert M Cohen; Matthew C Riddle; Michael E Miller; John B Buse; Denise E Bonds; Kevin A Peterson; Yves D Rosenberg; Letitia H Perdue; Barbara A Esser; Lea A Seaquist; James V Felicetta; Emily Y Chew
Journal:  Arch Ophthalmol       Date:  2010-03

5.  Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes.

Authors:  Martial G Bourassa; Colin Berry
Journal:  Curr Atheroscler Rep       Date:  2008-04       Impact factor: 5.113

Review 6.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

7.  Thiazolidinediones: a 2010 perspective.

Authors:  Ashok Krishnaswami; Shalini Ravi-Kumar; John M Lewis
Journal:  Perm J       Date:  2010

Review 8.  The forgotten type 2 diabetes mellitus medicine: rosiglitazone.

Authors:  Bo Xu; Aoxiang Xing; Shuwei Li
Journal:  Diabetol Int       Date:  2021-06-29

9.  Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials.

Authors:  Hammad A Qazi
Journal:  J Res Med Sci       Date:  2012-12       Impact factor: 1.852

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.